Morningstar Investment Services LLC Novartis Ag Transaction History

Morningstar Investment Services LLC

$9.8 Billion
Q3 2024

A detailed history of Morningstar Investment Services LLC transactions in Novartis Ag stock. As of the latest transaction made, Morningstar Investment Services LLC holds 375,916 shares of NVS stock, worth $39.9 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

375,916

Previous 374,998 0.24%

Holding current value

$39.9 Million

Previous $40 Million 8.77%

% of portfolio

0.44%

Previous 0.43%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$106.13 - $120.89 $97,427 - $110,977	918 Added 0.24%	375,916 $43.5 Million
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $370,650 - $429,909	4,004 Added 1.08%	374,998 $40 Million
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $35.8 Million - $40.8 Million	-375,842 Reduced 50.32%	370,994 $35.6 Million
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $34.3 Million - $37.7 Million	371,590 Added 99.03%	746,836 $74.7 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $588,178 - $652,752	-6,209 Reduced 1.63%	375,246 $38.4 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $1.08 Million - $1.22 Million	-11,658 Reduced 2.97%	381,455 $37.8 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $31.5 Million - $36.5 Million	393,113 New	393,113 $36.2 Million
Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $1.08 Million - $1.33 Million	-14,350 Reduced 3.42%	405,395 $37.2 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $534,506 - $625,130	-7,164 Reduced 1.68%	419,745 $33.4 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $175,372 - $204,187	-2,178 Reduced 0.51%	426,909 $36.1 Million
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $69,695 - $78,839	870 Added 0.2%	429,087 $37.7 Million
Q4 2021 Feb 01, 2022	SELL	$79.7 - $88.13 $511,594 - $565,706	-6,419 Reduced 1.48%	428,217 $37.4 Million
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $353,698 - $411,480	-4,325 Reduced 0.99%	434,636 $36 Million
Q2 2021 Aug 12, 2021	SELL	$85.24 - $94.15 $133,144 - $147,062	-1,562 Reduced 0.35%	438,961 $40.3 Million
Q1 2021 May 11, 2021	SELL	$83.5 - $98.47 $2.43 Million - $2.87 Million	-29,131 Reduced 6.2%	440,523 $38.3 Million
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $1.53 Million - $1.85 Million	-19,558 Reduced 4.0%	469,654 $44.3 Million
Q3 2020 Nov 10, 2020	SELL	$82.14 - $91.0 $963,337 - $1.07 Million	-11,728 Reduced 2.34%	489,212 $42.6 Million
Q2 2020 Jul 30, 2020	SELL	$80.93 - $91.1 $1.65 Million - $1.86 Million	-20,380 Reduced 3.91%	500,940 $43.7 Million
Q1 2020 May 04, 2020	BUY	$70.67 - $99.01 $8.76 Million - $12.3 Million	123,924 Added 31.18%	521,320 $42.7 Million
Q4 2019 Feb 10, 2020	SELL	$84.35 - $95.37 $441,319 - $498,975	-5,232 Reduced 1.3%	397,396 $37.6 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $1.07 Million - $1.18 Million	-12,560 Reduced 3.03%	402,628 $35 Million
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $791,096 - $973,657	-10,492 Reduced 2.46%	415,188 $37.9 Million
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $1.2 Million - $1.37 Million	-15,923 Reduced 3.61%	425,680 $40.9 Million
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $1.7 Million - $1.89 Million	-23,055 Reduced 4.96%	441,603 $37.9 Million
Q3 2018 Nov 08, 2018	SELL	$66.94 - $77.43 $1.31 Million - $1.51 Million	-19,506 Reduced 4.03%	464,658 $40 Million
Q2 2018 Aug 03, 2018	BUY	$64.91 - $73.36 $224,523 - $253,752	3,459 Added 0.72%	484,164 $36.6 Million
Q1 2018 May 10, 2018	BUY	$70.39 - $84.15 $2.73 Million - $3.27 Million	38,807 Added 8.78%	480,705 $38.9 Million
Q4 2017 Feb 08, 2018	BUY	$72.33 - $77.64 $1.71 Million - $1.83 Million	23,630 Added 5.65%	441,898 $37.1 Million
Q3 2017 Nov 09, 2017	BUY	$74.14 - $77.27 $31 Million - $32.3 Million	418,268	418,268 $35.9 Million

Others Institutions Holding NVS

# of Institutions

1,439

Shares Held

135M

Call Options Held

1.12M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morningstar Investment Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morningstar Investment Services LLC with notifications on news.

Account

Morningstar Investment Services LLC Novartis Ag Transaction History